AOD-9604 Peptide: What Is It and What Are Its Potential Benefits for Fat Loss?

AOD-9604 is a peptide, meaning a short chain of amino acids. Amino acids are the building blocks your body uses to make proteins.

Scientists created AOD-9604 by modifying a small section of human growth hormone. Their goal was to investigate whether this smaller piece could affect fat metabolism without producing all the effects of the full hormone.

Fat metabolism simply means how the body makes, stores, breaks down, and uses fat. [4]

Although AOD-9604 comes from part of the growth hormone structure, it should not be treated as interchangeable with HGH.

Researchers investigated whether AOD-9604 could influence the way the body handles fat.

Two useful terms explain the idea:

• Lipolysis: breaking down stored fat.
• Fat oxidation: using fat for energy.

Some animal studies found increased fat breakdown and fat use after treatment with AOD-9604. Researchers also observed less weight gain in certain obese animal models. [1, 2]

In everyday language, scientists wanted to know whether the peptide could help the body release and use stored fat.

However, an effect on fat metabolism does not automatically mean meaningful weight loss. Human trials are needed to show whether the proposed effect leads to a useful result.

The possible benefits discussed below come mainly from early animal and laboratory research. They should be understood as research findings, rather than benefits people can expect.

1. It May Increase Fat Breakdown

In a study involving obese rats, AOD-9604 increased fat-breakdown activity in fat tissue.

This finding helped explain why researchers considered it a possible obesity treatment. However, it does not establish that AOD-9604 reliably reduces body fat in humans. [1]

2. It May Increase the Use of Fat for Energy

A study in obese mice found increased fat oxidation after AOD-9604 treatment.

This means the animals used more fat as fuel under the conditions studied. Whether AOD-9604 produces a meaningful, lasting effect like this in people remains unproven. [2]

3. It Reduced Weight Gain in Some Animal Studies

Some treated animals gained less weight than untreated animals.

This distinction matters: gaining less weight is not the same as losing existing weight. For example, an animal that gains 10 grams instead of 20 grams has gained less weight, but it has not lost weight.

The animal results were promising enough to justify further research, but they cannot establish the results a person would experience. [1, 2]

4. It Was Designed to Avoid Some Effects of Full Growth Hormone

Full-length growth hormone affects more than body fat. It also influences growth signals and blood sugar regulation.

Researchers hoped AOD-9604 could affect fat metabolism without producing the same wider effects. Early human safety reports found no significant changes in IGF-1, a growth-related hormone, or harmful changes in glucose handling under the conditions studied.

These findings do not prove that AOD-9604 is free from side effects or safe for long-term use. [4]

Current evidence does not establish AOD-9604 as an effective fat-loss treatment in humans.

The most important distinction is between the encouraging animal studies and the disappointing results of the larger human trial.

An FDA review describes a trial involving more than 500 adults with obesity. Participants received oral AOD-9604 or placebo, alongside a diet and exercise program.

AOD-9604 did not produce a statistically significant weight-loss advantage over placebo at 12 or 24 weeks. In simple terms, the study did not provide convincing evidence that the peptide caused additional weight loss. The developer subsequently ended its obesity development program. [6]

This does not prove that the compound has no biological effects. It means the available human evidence does not support presenting it as a proven weight-loss treatment.

There is no reliable, evidence-based answer to claims such as:

• “How many kilograms will I lose?”
• “How quickly does AOD-9604 work?”
• “Will it reduce my waist size?”
• “Will injections work better than tablets?”

The larger weight-loss trial used oral AOD-9604. Its results do not establish that injections work, and early oral safety findings cannot establish the safety of repeated injections. The FDA review identified important gaps in evidence for the proposed routes of use. [6]

Before-and-after photographs and personal stories also cannot show how much change came from a peptide, diet, exercise, other treatments, or normal weight fluctuations.

AOD-9604 and HGH are related, but they are different substances.

Animal and laboratory experiments found that AOD-9604 did not interact with the growth hormone receptor in the same way as HGH. Therefore, evidence about HGH cannot simply be used to claim that AOD-9604 produces the same benefits. [2, 10]

The full side-effect profile is not established.

A published report covering six human trials described generally favorable tolerability under the conditions studied. However, FDA reviewers highlighted limitations, including incomplete reporting and limited study duration. [4, 8]

The FDA has also raised concerns about:

• Possible immune reactions.
• Peptide-related impurities and difficulties characterizing the ingredient.
• Limited safety information.
• Serious adverse events potentially associated with AOD-9604, although it is unclear whether the peptide caused them. [7]

An immune reaction happens when the body’s defense system responds to a substance.

Statements such as “no side effects” or “completely safe” go beyond what the available research can support.

AOD-9604 is not an FDA-approved weight-loss medicine. FDA assessments have identified insufficient evidence of effectiveness and important safety uncertainties. [6]

You may also see references to GRAS, meaning “generally recognized as safe,” in discussions of potential food uses.

Food-use safety assessments are different from drug approval. They do not establish that AOD-9604 injections are safe or that the peptide works for weight loss. [5, 6]

AOD-9604 is scientifically interesting because early experiments suggested that a small growth hormone fragment could affect fat metabolism.

However, three points are essential:

1. Animal results do not guarantee human results.
2. Changes in fat breakdown do not automatically produce lasting fat loss.
3. The larger human trial did not demonstrate a clear weight-loss benefit over placebo.

The most accurate description is an experimental peptide with promising preclinical findings but unproven fat-loss benefits in humans. [1, 2, 6]

What Is AOD-9604 Used For?

AOD-9604 was developed as an experimental obesity treatment. Researchers investigated whether it could influence fat metabolism without producing all the effects of full-length growth hormone. It has not been established as an effective human fat-loss treatment. [4, 6]

Does AOD-9604 Burn Fat?

Some animal studies found increased fat breakdown and use of fat for energy. However, these findings do not establish reliable fat loss in people. The larger human trial did not show a statistically significant weight-loss advantage over placebo. [1, 2, 6]

Does AOD-9604 Help with Belly Fat?

There is not enough reliable human evidence to claim that AOD-9604 specifically reduces belly fat or the deeper fat around internal organs.

The larger trial’s weight-loss results do not justify promises about losing fat from a particular body area. [6]

How Long Does AOD-9604 Take to Work?

There is no established timeline for effective fat loss in humans. Claims that it produces predictable results within a set number of weeks are not supported by strong clinical evidence. [6]

How Much Weight Can You Lose with AOD-9604?

No dependable amount can be given. In the larger human trial, AOD-9604 did not demonstrate a statistically significant weight-loss benefit over placebo. [6]

Is AOD-9604 the Same as HGH?

No. AOD-9604 is a modified fragment based on a small part of HGH. HGH is the full hormone and has wider effects throughout the body. [2, 4]

Does AOD-9604 Increase Growth Hormone or IGF-1?

AOD-9604 should not be described as an established growth hormone booster. The published human safety report found no significant effect on blood IGF-1 levels under the conditions studied. [4]

Does AOD-9604 Build Muscle?

There is no convincing clinical evidence that AOD-9604 builds muscle in humans. Its relationship to growth hormone does not mean it produces the same growth-related effects. [2, 6]

Are AOD-9604 Injections Better Than Tablets?

There is insufficient reliable human evidence to establish that injections are more effective for fat loss. The larger obesity trial used oral treatment, while evidence supporting repeated injections remains limited. [4, 6]

Is AOD-9604 Safe?

Its overall and long-term safety are not established. Early human studies reported favorable tolerability, but FDA reviews identified important evidence gaps and potential safety concerns. [4, 6, 7]

What Is the Recommended AOD-9604 Dosage for Fat Loss?

There is no FDA-approved AOD-9604 dosage for weight loss. Experimental trial doses do not provide an established self-treatment regimen, especially when the route of administration differs. [6]

Is AOD-9604 the Same as HGH Fragment 176–191?

The names are sometimes used loosely in marketing, but they should not automatically be treated as interchangeable. AOD-9604 is a specific modified fragment, described as growth hormone residues 177–191 with an added tyrosine. Exact peptide structure matters when interpreting research. [4]

1. Ng FM, et al. (2000). Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Hormone Research.
2. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment (2001). International Journal of Obesity.
3. Heffernan M, et al. (2001). The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology.
4. Stier H, Vos E, Kenley D. (2013). Safety and tolerability of the hexadecapeptide AOD9604 in humans. Journal of Endocrinology and Metabolism.
5. Moré, et al. (2014). Safety and metabolism of AOD9604, a novel nutraceutical ingredient for improved metabolic health. Journal of Endocrinology and Metabolism.
6. U.S. Food and Drug Administration. (2024). AOD-9604-related bulk drug substances: Pharmacy Compounding Advisory Committee briefing document.
7. U.S. Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks.
8. U.S. Food and Drug Administration. (2024). Pharmacy Compounding Advisory Committee presentations.
9. Society for Endocrinology. Growth hormone. Your Hormones.
10. Endotext. Normal physiology of growth hormone in normal adults.
11. National Institute of Diabetes and Digestive and Kidney Diseases. Understanding adult overweight and obesity.
12. National Institutes of Health. Explaining how research works.